These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9719643)

  • 1. Solution structure of acidic fibroblast growth factor bound to 1,3, 6-naphthalenetrisulfonate: a minimal model for the anti-tumoral action of suramins and suradistas.
    Lozano RM; Jiménez M; Santoro J; Rico M; Giménez-Gallego G
    J Mol Biol; 1998 Sep; 281(5):899-915. PubMed ID: 9719643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leads for development of new naphthalenesulfonate derivatives with enhanced antiangiogenic activity: crystal structure of acidic fibroblast growth factor in complex with 5-amino-2-naphthalene sulfonate.
    Fernández-Tornero C; Lozano RM; Redondo-Horcajo M; Gómez AM; López JC; Quesada E; Uriel C; Valverde S; Cuevas P; Romero A; Giménez-Gallego G
    J Biol Chem; 2003 Jun; 278(24):21774-81. PubMed ID: 12676958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional structure of acidic fibroblast growth factor in solution: effects of binding to a heparin functional analog.
    Pineda-Lucena A; Jiménez MA; Lozano RM; Nieto JL; Santoro J; Rico M; Giménez-Gallego G
    J Mol Biol; 1996 Nov; 264(1):162-78. PubMed ID: 8950275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New sulfonated distamycin A derivatives with bFGF complexing activity.
    Ciomei M; Pastori W; Mariani M; Sola F; Grandi M; Mongelli N
    Biochem Pharmacol; 1994 Jan; 47(2):295-302. PubMed ID: 7508230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factors and their inhibitors.
    Botta M; Manetti F; Corelli F
    Curr Pharm Des; 2000 Dec; 6(18):1897-924. PubMed ID: 11102567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abolished angiogenicity and tumorigenicity of rat glioma by 1-naphthalenemonosulfonate.
    Cuevas P; Carceller F; Diaz D; Reimers D; Fernández M; Lozano RM; González-Corrochano R; Giménez-Gallego G
    Neurosci Lett; 2001 Aug; 308(3):185-8. PubMed ID: 11479019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solution structure of human acidic fibroblast growth factor and interaction with heparin-derived hexasaccharide.
    Ogura K; Nagata K; Hatanaka H; Habuchi H; Kimata K; Tate S; Ravera MW; Jaye M; Schlessinger J; Inagaki F
    J Biomol NMR; 1999 Jan; 13(1):11-24. PubMed ID: 10070748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1H-NMR assignment and solution structure of human acidic fibroblast growth factor activated by inositol hexasulfate.
    Pineda-Lucena A; Jiménez MA; Nieto JL; Santoro J; Rico M; Giménez-Gallego G
    J Mol Biol; 1994 Sep; 242(1):81-98. PubMed ID: 7521397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-angiogenic activity of heparin-like polysulfonated polymeric drugs in 3D human cell culture.
    García-Fernández L; Halstenberg S; Unger RE; Aguilar MR; Kirkpatrick CJ; San Román J
    Biomaterials; 2010 Nov; 31(31):7863-72. PubMed ID: 20674006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and binding mode of heterocyclic analogues of suramin inhibiting the human basic fibroblast growth factor.
    Manetti F; Cappello V; Botta M; Corelli F; Mongelli N; Biasoli G; Borgia AL; Ciomei M
    Bioorg Med Chem; 1998 Jul; 6(7):947-58. PubMed ID: 9730230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel in vitro assay for human angiogenesis.
    Brown KJ; Maynes SF; Bezos A; Maguire DJ; Ford MD; Parish CR
    Lab Invest; 1996 Oct; 75(4):539-55. PubMed ID: 8874385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular level interaction of the human acidic fibroblast growth factor with the antiangiogenic agent, inositol hexaphosphate .
    Kumar SM; Wang HM; Mohan SK; Chou RH; Yu C
    Biochemistry; 2010 Dec; 49(50):10756-64. PubMed ID: 21077672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis of glioma cells induced by the fibroblast growth factor inhibitor 1,3,6-naphthalenetrisulfonate.
    Cuevas P; Reimers D; Diaz D; Lozano RM; Giménez-Gallego G
    Neurosci Lett; 1999 Nov; 275(2):149-51. PubMed ID: 10568521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible dissociation of the heparin-binding and mitogenic activities of heparin-binding (acidic fibroblast) growth factor-1 from its receptor-binding activities by site-directed mutagenesis of a single lysine residue.
    Burgess WH; Shaheen AM; Ravera M; Jaye M; Donohue PJ; Winkles JA
    J Cell Biol; 1990 Nov; 111(5 Pt 1):2129-38. PubMed ID: 1699952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of acidic fibroblast growth factor-dependent angiogenesis by the antigrowth activity of 1,3,6-naphthalenetrisulfonate.
    Cuevas P; Lozano RM; Giménez-Gallego G
    Neurol Res; 1999 Mar; 21(2):191-4. PubMed ID: 10100207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polysulfated heparinoids selectively inactivate heparin-binding angiogenesis factors.
    Zugmaier G; Favoni R; Jaeger R; Rosen N; Knabbe C
    Ann N Y Acad Sci; 1999; 886():243-8. PubMed ID: 10667230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Destabilization, oligomerization and inhibition of the mitogenic activity of acidic fibroblast-growth factor by aurintricarboxylic acid.
    Lozano RM; Rivas G; Giménez-Gallego G
    Eur J Biochem; 1997 Aug; 248(1):30-6. PubMed ID: 9310356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long pentraxin-3 as an epithelial-stromal fibroblast growth factor-targeting inhibitor in prostate cancer.
    Ronca R; Alessi P; Coltrini D; Di Salle E; Giacomini A; Leali D; Corsini M; Belleri M; Tobia C; Garlanda C; Bonomi E; Tardanico R; Vermi W; Presta M
    J Pathol; 2013 Jun; 230(2):228-38. PubMed ID: 23424081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction of a chemical constraint in a short peptide derived from human acidic fibroblast growth factor elicits mitogenic structural determinants.
    Kiyota S; Franzoni L; Nicastro G; Benedetti A; Oyama S; Viviani W; Gambarini AG; Spisni A; Miranda MT
    J Med Chem; 2003 Jun; 46(12):2325-33. PubMed ID: 12773037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the mitogenic, angiogenic and tumorigenic activities of pleiotrophin by a synthetic peptide corresponding to its C-thrombospondin repeat-I domain.
    Hamma-Kourbali Y; Bernard-Pierrot I; Heroult M; Dalle S; Caruelle D; Milhiet PE; Fernig DG; Delbé J; Courty J
    J Cell Physiol; 2008 Jan; 214(1):250-9. PubMed ID: 17607711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.